Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-343935.00.
ENTERPRISE VALUE (EV)
$-343935.00
XORTX Therapeutics Inc.
Market Cap
$481786.00
Enterprise Value (EV)
$-343935.00
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| XORTX Therapeutics Inc. (XRTX) | $481786.00 | $-343935.00 |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | N/A |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | $6.37M |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | $393924.00 |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | N/A |
| CDT Equity Inc. (CDT)vs › | $716854.00 | $971.29M |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | N/A |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | N/A |
Market Cap
$481786.00
Total Debt
$37219.00
Cash
$862940.00
Enterprise Value
$-343935.00
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
